ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 139021 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 139021; 2) Community: the network communities that were significantly associated with the response to NSC 139021; 3) Molecule: the relationships between components within communities and NSC 139021; 4) MDR: the compounds that were significantly associated with the NSC 139021.

NSC Compound Enrichment Correlation
NSC 720386 Methyl-12.alpha.-acetoxy-5.beta.cholan-24-oate-3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclohexane 0.00356914129105577 0.41847625
NSC 722854 1,4-di-N-oxide-2-phenylcarbonyl-3-trifluoromethylquinoxaline 0.00356914129105577 0.63316605
NSC 743876 Null 0.00356914129105577 0.31793787
NSC 758881 Orlistat (USAN) 0.00356914129105577 0.48705046
NSC 762559 Null 0.00356914129105577 -0.11469379
NSC 332837 Carbamothioic acid, dimethyl-, S-[2-(2,6-dichlorophenyl)-1-oxo-1H-inden-3-yl] ester 0.0038671642008129 0.50012677
NSC 605440 Isothiazolo[2,3-a]azepine, 5,7-bis(trifluoromethyl)- 2,3-dihydro-, 1,1-dioxide 0.0038671642008129 0.58247446
NSC 622282 4H-1-Benzothiopyran-4-one, 2-(methylsulfonyl)- 0.0038671642008129 0.46043707
NSC 627744 Null 0.0038671642008129 0.5341357
NSC 634785 4-Piperidinone, 1-[3-(diethylamino)-1-oxopropyl]-3,5-bis- (phenylmethylene)-, monohydrochloride 0.0038671642008129 0.40835397
Total:115  Current:15    [First] [Prev] [Next] [Last]